BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 1491242)

  • 1. The history of drugs for the treatment of Parkinson's disease.
    Kapp W
    J Neural Transm Suppl; 1992; 38():1-6. PubMed ID: 1491242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
    Hornykiewicz O
    Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy in Parkinson's disease].
    van Hilten JJ; Roos RA
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease. A half century of progress.
    Jankovic J
    Neurology; 2001 Nov; 57(10 Suppl 3):S1-3. PubMed ID: 11771154
    [No Abstract]   [Full Text] [Related]  

  • 6. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
    Lees AJ; Tolosa E; Olanow CW
    Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short history of L-Dopa].
    García Ruiz PJ; Meseguer E
    Neurologia; 2002 Apr; 17(4):214-7. PubMed ID: 11940409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medical treatment of Parkinson disease from James Parkinson to George Cotzias.
    Fahn S
    Mov Disord; 2015 Jan; 30(1):4-18. PubMed ID: 25491387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Madopar: more than 20 years].
    Leiva C
    Rev Neurol; 1997 Dec; 25(148):1957-63. PubMed ID: 9528041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The history of dopamine and levodopa in the treatment of Parkinson's disease.
    Fahn S
    Mov Disord; 2008; 23 Suppl 3():S497-508. PubMed ID: 18781671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resurgence of functional neurosurgery for Parkinson's disease: a historical perspective.
    Speelman JD; Bosch DA
    Mov Disord; 1998 May; 13(3):582-8. PubMed ID: 9613759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern therapy of Parkinson's disease.
    Ransmayr G; Künig G; Gerstenbrand F
    J Neural Transm Suppl; 1992; 38():129-40. PubMed ID: 1491245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Insight: new drugs in development for Parkinson's disease.
    Colosimo C; Fabbrini G; Berardelli A
    Nat Clin Pract Neurol; 2006 Nov; 2(11):600-10. PubMed ID: 17057747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The history of Parkinson's disease: early clinical descriptions and neurological therapies.
    Goetz CG
    Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a008862. PubMed ID: 22229124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 200 Years of Parkinson's disease: what have we learnt from James Parkinson?
    McDonald C; Gordon G; Hand A; Walker RW; Fisher JM
    Age Ageing; 2018 Mar; 47(2):209-214. PubMed ID: 29315364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in clinical therapeutics: Parkinson's disease.
    Erwin WG; Turco TF
    Clin Pharm; 1986 Sep; 5(9):742-53. PubMed ID: 3530616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship.
    Parent M; Parent A
    Can J Neurol Sci; 2010 May; 37(3):313-9. PubMed ID: 20481265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.